Literature DB >> 2574821

Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family.

R Roskoski1, L White, R Knowlton, L M Roskoski.   

Abstract

Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis, is subject to regulation by the cAMP as well as the calcium and cGMP second messenger systems. Treatment of intact rat PC12 cells with neuropeptides including secretin and vasoactive intestinal polypeptide (VIP) stimulated tyrosine hydroxylase activity 2 to 3-fold in vitro. Secretin (EC50 = 10 nM) was about 3 orders of magnitude more potent than VIP (EC50 = 3 microM). A combination of several protease inhibitors failed to enhance the potency of either peptide. Other members of the secretin family including glucagon and peptide histidine isoleucine (PHI) stimulated tyrosine hydroxylase activity to a lesser extent. Somatostatin, which is not homologous to secretin, was ineffective. The maximal response of tyrosine hydroxylase activation to 1 microM secretin occurred within 6-15 sec. Secretin, VIP, and forskolin also enhanced tyrosine hydroxylase activity (3,4-dihydroxyphenylalanine production) in intact cells, as determined by high performance liquid chromatography and electrochemical detection. Secretin, VIP, PHI, and glucagon increased the levels of cAMP in PC12 cells more than 10-fold, as determined by radioimmunoassay. We also demonstrated that cAMP is released from the cells into the incubation medium following secretin treatment. Secretin and VIP treatment also enhanced the activity of cAMP-dependent protein kinase in a concentration-dependent fashion, as measured subsequently in vitro. Based on the greater potency of secretin in comparison with VIP, PHI, and glucagon, we suggest that the PC12 cells contain a secretin-preferring receptor that increases cAMP levels and brings about an activation of tyrosine hydroxylase activity through the stimulation of cAMP-dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574821

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Secretin mRNA in the subdivision of primary sensory neurons in the trigeminal ganglion of rats.

Authors:  Andrea Heinzlmann; Zsuzsanna E Tóth; Katalin Köves
Journal:  J Mol Neurosci       Date:  2010-06-26       Impact factor: 3.444

2.  Secretin attenuates the hereditary repetitive hyperactive movements in a mouse model.

Authors:  Katalin Köves; Gusztav Kiss; Andrea Heinzlmann; Roberta Dochnal; M Manczinger; Agnes Pál; I Sípos; Gyula Szabó
Journal:  J Mol Neurosci       Date:  2010-07-06       Impact factor: 3.444

3.  Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.

Authors:  Misu Lee; Beatrice Waser; Jean-Claude Reubi; Natalia S Pellegata
Journal:  Mol Endocrinol       Date:  2012-06-12

4.  Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector.

Authors:  A I Geller; M J During; J W Haycock; A Freese; R Neve
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

5.  Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A.

Authors:  M Hagiwara; P Brindle; A Harootunian; R Armstrong; J Rivier; W Vale; R Tsien; M R Montminy
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

6.  Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury.

Authors:  R P Mohney; R E Zigmond
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

7.  Molecular cloning and expression of a cDNA encoding the secretin receptor.

Authors:  T Ishihara; S Nakamura; Y Kaziro; T Takahashi; K Takahashi; S Nagata
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.